Facial Injectible Market By Type 2022 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Facial Injectible Market
Facial Injectible Market: By Type (Hyaluronic Acid, Collagen, Botulinum Toxin, Polymers & Particles); By Application (Facial Surgery, Facial Uplift); By End Users (Hospitals, Clinics, Research and Development Facilities) & By Region-Forecast (2016-2022)
Report Code : HCR 0414
Updated Date: 20 September, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
Facial Injectible, also commonly known as Dermal Fillers, are the products used for aesthetic purposes such as anti-aging and enhancing the appearance of facial skin and help in a trending application known as bio-engineering or facial rejuvenation. As humans age, the facial skin is bound to lose subcutaneous fat naturally, the skin is lured closer to the facial working muscles. Hence, smile lines and wrinkles over the face become more visible. Globally, an increasing aged population pool and increasing spending on healthcare are expected to be the key driving factors for the facial injectible market during the period of study.

 Facial Injectible Market

Geographically, North America dominated the facial injectible market driven by a high number of aged and adult population, higher awareness, higher spending on such treatment, presence of world class infrastructure and service providers and stringent guidelines in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for the facial injectible market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing healthcare infrastructure and rising healthcare spending in developing nations such as China and India in this region.

This report identifies the facial injectible market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the facial injectible market.

This report segments the facial injectible market on the basis of type, application, end-user and regional market as follows:
  • Facial Injectible market research report is classified on the basis of type. Some of the major types covered in this report are as follows: Hyaluronic Acid, Collagen, Botulinum Toxin, Polymers & Particles and Others
  • Facial Injectible market research report is classified on the basis of application. Some of the major applications covered in this report are as follows: Facial Surgery, Facial Uplift and Others
  • Facial Injectible market research report is classified on the basis of end-users. Some of the major end-users covered in this report are as follows: Hospitals, Clinics, Research and Development Facilities
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the facial injectible market. Some of the major companies’ profiles in detail are as follows:

  • Bloomega BioTechnology Corporation Limited
  • Allergan Inc (Ireland)
  • Merz Pharma (Germany)
  • Ipsen (France)
  • Valeant Pharmaceuticals (Canada)
1. Facial Injectible Market – Overview
2. Executive Summary
3. Facial Injectible Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Facial Injectible Market– Forces
   4.1. Drivers
      4.1.1. Increasing Adoption of Augmented Reality Devices
      4.1.2. Compact size of facial injectible
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Facial Injectible Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Facial Injectible Market, By Type
   6.1. Hyaluronic Acid
   6.2. Collagen
   6.3. Botulinum Toxin
   6.4. Polymers & Particles
   6.5. Others
7. Facial Injectible Market, By Application
   7.1. Facial Surgery
   7.2. Facial Uplift
   7.3. Others
8. Facial Injectible Market, By End-User
   8.1. Hospitals
   8.2. Clinics
   8.3. Research & Development Facilities
9. Facial Injectible Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Facial Injectible Market – Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. Bloomega BioTechnology Corporation Limited
   11.2. Allergan Inc (Ireland)
   11.3. Merz Pharma (Germany)
   11.4. Ipsen (France)
   11.5. Valeant Pharmaceuticals (Canada)
   11.6. Galderma (Switzerland)
   11.7. Integra Lifesciences (Us)
   11.8. Tei Biosciences
   11.9. Fibrogen (Finland)
   11.10. Ethicon (Us).
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix

   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll